Cargando…

Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

Coronavirus disease 2019 (COVID-19) induces a hypercoagulatory state that frequently leads to thromboembolic complications. Whereas anticoagulation is associated with reduced mortality, the role of antiplatelet therapy in COVID-19 is less clear. We retrospectively analyzed the effect of anticoagulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrottmaier, Waltraud C., Pirabe, Anita, Pereyra, David, Heber, Stefan, Hackl, Hubert, Schmuckenschlager, Anna, Brunnthaler, Laura, Santol, Jonas, Kammerer, Kerstin, Oosterlee, Justin, Pawelka, Erich, Treiber, Sonja M., Khan, Abdullah O., Pugh, Matthew, Traugott, Marianna T., Schörgenhofer, Christian, Seitz, Tamara, Karolyi, Mario, Jilma, Bernd, Rayes, Julie, Zoufaly, Alexander, Assinger, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818754/ https://www.ncbi.nlm.nih.gov/pubmed/35141292 http://dx.doi.org/10.3389/fcvm.2021.802566

Ejemplares similares

Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype
por: Schrottmaier, Waltraud C., et al.
Publicado: (2021)

Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers
por: Pirabe, Anita, et al.
Publicado: (2023)

Age Related Differences in Monocyte Subsets and Cytokine Pattern during Acute COVID-19—A Prospective Observational Longitudinal Study
por: Pirabe, Anita, et al.
Publicado: (2021)

Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5
por: Ercan, Huriye, et al.
Publicado: (2021)

Age-Dependent Surface Receptor Expression Patterns in Immature Versus Mature Platelets in Mouse Models of Regenerative Thrombocytopenia
por: Pirabe, Anita, et al.
Publicado: (2023)

Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study
por: Pereyra, David, et al.
Publicado: (2021)

Platelets in Viral Infections – Brave Soldiers or Trojan Horses
por: Schrottmaier, Waltraud C., et al.
Publicado: (2022)

Horizontal MicroRNA Transfer by Platelets – Evidence and Implications
por: Mussbacher, Marion, et al.
Publicado: (2021)

A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation
por: Heber, Stefan, et al.
Publicado: (2022)

Routine haematological parameters in COVID-19 prognosis
por: Pereyra, David, et al.
Publicado: (2020)

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort
por: Karolyi, Mario, et al.
Publicado: (2022)

Platelets in Sepsis: An Update on Experimental Models and Clinical Data
por: Assinger, Alice, et al.
Publicado: (2019)

Impact of Anticoagulation and Sample Processing on the Quantification of Human Blood-Derived microRNA Signatures
por: Mussbacher, Marion, et al.
Publicado: (2020)

Comprehensive Characterization of Platelet-Enriched MicroRNAs as Biomarkers of Platelet Activation
por: Krammer, Teresa L., et al.
Publicado: (2022)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
por: Karolyi, Mario, et al.
Publicado: (2021)

Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
por: Karolyi, M., et al.
Publicado: (2020)

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
por: Karolyi, M., et al.
Publicado: (2022)

Platelet Activation Is Not Always Associated With Platelet-Related Plasma microRNA Abundance – Results From a Randomized Controlled Trial of Periodontal Patients
por: Heber, Stefan, et al.
Publicado: (2021)

Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients: Results from a real-life patient cohort
por: Karolyi, Mario, et al.
Publicado: (2020)

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Transcriptomic landscapes of effective and failed liver regeneration in humans
por: Starlinger, Patrick, et al.
Publicado: (2023)

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
por: Karolyi, Mario, et al.
Publicado: (2021)

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022)

Measuring and interpreting platelet-leukocyte aggregates
por: Finsterbusch, Michaela, et al.
Publicado: (2018)

Comparison of clinical characteristics among patients infected with alpha vs. delta SARS-CoV-2 variants
por: Rumpf, Benedikt, et al.
Publicado: (2022)

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting
por: Seitz, Tamara, et al.
Publicado: (2022)

Reply
por: Starlinger, Patrick, et al.
Publicado: (2019)

Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report
por: Hoepler, Wolfgang, et al.
Publicado: (2021)

Optimized plasma preparation is essential to monitor platelet-stored molecules in humans
por: Mussbacher, Marion, et al.
Publicado: (2017)

COVID-19-associated myoclonus in a series of five critically ill patients
por: Grieb, Alexander, et al.
Publicado: (2021)

Till Death Do Us Part—The Multifaceted Role of Platelets in Liver Diseases
por: Mussbacher, Marion, et al.
Publicado: (2021)

Is there a clinical difference between influenza A and B virus infections in hospitalized patients?: Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018
por: Karolyi, Mario, et al.
Publicado: (2019)

Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
por: Ortmayr, Gregor, et al.
Publicado: (2021)

Successful management of the first reported case in Austria of COVID-19 with ARDS
por: Seitz, T., et al.
Publicado: (2020)

COVID-19 and thrombotic complications—the role of anticoagulants, antiplatelets and thrombolytics
por: Khandelwal, Gaurav, et al.
Publicado: (2021)

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays
por: Semmler, Georg, et al.
Publicado: (2021)

Calcium channel blockers reduce the antiplatelet effect of clopidogrel
por: Siller-Matula, Jolanta M, et al.
Publicado: (2008)

Muscle involvement in SARS‐CoV‐2 infection
por: Pitscheider, Lea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u2qer9mk23kotl1j4rqkvpqefe